EcoDrugPlus

Ensembl ID : ENSMMNG00015010952
Gene Symbol: -
Cross references: -
259 Possible Orthologues:

Ensembl ID : ENSMMNG00015010300
Gene Symbol: -
Cross references: -
108 Possible Orthologues:

Ensembl ID : ENSMMNG00015012059
Gene Symbol: -
Cross references: -
73 Possible Orthologues:

Ensembl ID : ENSMMNG00015013656
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSMMNG00015013585
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSMMNG00015005468
Gene Symbol: -
Cross references: -
328 Possible Orthologues:

Ensembl ID : ENSMMNG00015011602
Gene Symbol: -
Cross references: -
40 Possible Orthologues:

Ensembl ID : ENSMMNG00015012870
Gene Symbol: -
Cross references: -
84 Possible Orthologues:

Ensembl ID : ENSMMNG00015014420
Gene Symbol: -
Cross references: -
48 Possible Orthologues:

Ensembl ID : ENSMMNG00015004740
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSMMNG00015018817
Gene Symbol: -
Cross references: -
255 Possible Orthologues:

Ensembl ID : ENSMMNG00015013154
Gene Symbol: -
Cross references: -
316 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).